INVESTMENT SECURITIES (Details Narrative) - USD ($)	3 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021
Common Stock [Member] \| Zander Therapeutics
Sale of Stock, Number of Shares Issued in Transaction	18,300
Proceeds from Issuance or Sale of Equity	$ 25,000
Unrelated Party [Member]
Sale of Stock, Number of Shares Issued in Transaction		18,000	13,700
Proceeds from Issuance or Sale of Equity		$ 195,000	$ 300,000

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585

Name:	us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration